The role of pharmacokinetics in bioequivalence of studies of inhalation drugs

• In: MINI-SYMPOSIUM: CHALLENGES IN BIOEQUIVALENCE FOR INHALED PRODUCTS on Monday, 14 April 2014, 09:00-10:00
• At: PSWC, Melbourne (Australia) (2014)
• Type: Presentation
• By: HOCHHAUS, Guenther (University of Florida, Pharmaceutics, Gainesville, United States of America)
• Abstract:

  I. Background: Demonstrating the bioequivalence of inhaltion drugs is a challenge. Currently in vitro, pharmacokinetic and pharmacodynamic clinical studies are employed with european (EMA) and north-american (FDA) differing significantly 2. Aims: Aim of this presentation is it to discuss advantages and disadvantages of above methods. 3. Methods:..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login